A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia. (Q53934150)

22 May 2018

title

A flow cytometric method to detect apoptosis-related protein expression in minimal residual disease in acute myeloid leukemia. (English)

1 reference

22 May 2018

1 reference

van Stijn A

1

1 reference

22 May 2018

Kok A

2

1 reference

22 May 2018

van der Pol MA

3

1 reference

22 May 2018

Feller N

4

1 reference

22 May 2018

Roemen GM

5

1 reference

22 May 2018

Westra AH

6

1 reference

22 May 2018

Ossenkoppele GJ

7

1 reference

22 May 2018

Schuurhuis GJ

8

1 reference

22 May 2018

publication date

1 April 2003

1 reference

22 May 2018

published in

Leukemia

1 reference

22 May 2018

volume

17

1 reference

22 May 2018

issue

4

1 reference

22 May 2018

page(s)

780-786

1 reference

22 May 2018

https://scigraph.springernature.com/pub.10.1038/sj.leu.2402885

exact match

0 references

cites work

Acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's Leukaemia Working Par

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Immunophenotypical detection of minimal residual disease in acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

CD34 and CD117 are overexpressed in AML and may be valuable to detect minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

The relationship between bcl-2 expression and response to chemotherapy in acute leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Apaf-1 protein deficiency confers resistance to cytochrome c-dependent apoptosis in human leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Disturbed expression of the anti-apoptosis gene, survivin, and EPR-1 in hematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

7 January 2021

Specificity of immunophenotyping in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

7 January 2021

Functional characterization of minimal residual disease for P-glycoprotein and multidrug resistance protein activity in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

7 January 2021

High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

7 January 2021

Quantitative fluorescence cytometric analysis of Bcl-2 levels in tumor cells exhibiting a wide range of inherent Bcl-2 protein expression: correlation with Western blot analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

7 January 2021

Flow cytometry CD45 gating for immunophenotyping of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

7 January 2021

Expression of Bcl-2-related genes in normal and AML progenitors: changes induced by chemotherapy and retinoic acid

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2402885

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2402885

1 reference

22 May 2018

PubMed ID

12682637

1 reference

22 May 2018